Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from IXICO plc ( (GB:IXI) ).
IXICO plc has closed its recently launched UK retail offer, raising £30,320 through the issue of 379,000 new shares at 8.0 pence each, as part of a wider fundraising. Together with associated placings and a subscription priced at the same level, the company has conditionally secured approximately £10 million in gross proceeds to support its operations.
The fundraising will be completed in two stages, with first admission of 36.7 million new shares expected around 17 April 2026 and, subject to conditions, a second admission of 88.7 million shares around 20 April 2026. If the second admission conditions are not met by 19 May 2026, that tranche will lapse, leaving IXICO with a smaller capital raise but still materially enlarged share capital and increased funding firepower for its strategic plans.
The most recent analyst rating on (GB:IXI) stock is a Hold with a £7.50 price target. To see the full list of analyst forecasts on IXICO plc stock, see the GB:IXI Stock Forecast page.
Spark’s Take on IXI Stock
According to Spark, TipRanks’ AI Analyst, IXI is a Neutral.
The score is held back primarily by weak financial performance (ongoing losses and negative operating cash flow) and very bearish technicals (below key moving averages with negative MACD). A positive offset comes from supportive earnings-call guidance and order book growth, but valuation remains constrained by the company’s loss-making profile.
To see Spark’s full report on IXI stock, click here.
More about IXICO plc
IXICO plc is a UK-based company that provides neuroimaging and digital biomarker services to the pharmaceutical and biotechnology industries. The business focuses on supporting clinical trials in neurological disorders, leveraging advanced imaging analytics to improve the development and assessment of therapies in this specialist market.
Average Trading Volume: 167,581
Technical Sentiment Signal: Sell
Current Market Cap: £7.3M
Find detailed analytics on IXI stock on TipRanks’ Stock Analysis page.